TSXV:TRL.H - Post by User
Post by
knollon Feb 09, 2017 7:18pm
398 Views
Post# 25825746
bit of promising news
bit of promising newsATYU Bioscience posted there 2nd quarter stating much improvement with Natesto sales and prescribers. Better management could have co-ordianted a release with Aytu - would have actually said something. Seems like ATYU is the only one doing anything to market the soon to be released in Canada Natesto.
https://web.tmxmoney.com/article.php?newsid=6658589834641252&qm_symbol=AYTU:US Management Discussion:
"Aytu's second fiscal quarter was exceptional across multiple fronts as the company continued to execute on its plan of launching Natesto in the U.S., positioning MiOXSYS for market expansion outside the U.S., and efficiently operating our growing commercial-stage business," said Josh Disbrow, Chairman and Chief Executive Officer of Aytu BioScience, Inc. "Natesto has continued to reach new highs with respect to both prescriptions filled and the number of prescribers, and at this very early stage, gross product sales have already reached an annualized run rate of nearly $1.6 million based on real prescription demand. We're adding new Natesto prescribers every month and are building a diverse base of high-decile prescribers through the focused, efficient sales efforts of our 35-strong urology sales force. With this continued prescription trajectory, supported by a growing base of prescribers, we expect to be generating approximately 100 prescriptions per week by midsummer and have full confidence that the Natesto launch will continue to unfold successfully."